Optimizing heart failure therapy with implantable sensors

• Lau Chu-Pak

  Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital

• Siu David C.W.

  Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital

• Tse Hung-Fat

  Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital

抄録

Heart failure (HF)-related hospitalization is associated with significant mortality and morbidity and can be prevented by early intervention. Implantable sensors detect early pathophysiological changes in HF, using an accelerometer, a paced electrogram, impedance and pressure sensors in implanted intracardiac leads, or stand-alone devices. Such sensors monitor daily activity, QT and ST intervals, pulmonary fluid, and intracardiac pressures at various points. Sensor data are available either by patient’s or physician’s regular interrogation, or using remote patient monitoring. Different sensors have different levels of sensitivity and specificity for HF detection, and they have the ability to antedate HF exacerbation and thereby allow for the initiation of intervention to avert decompensation. Clinical studies suggest that alone or in combination, such sensors have a greater beneficial impact than conventional therapy on acute HF outcome.

収録刊行物

• Journal of Arrhythmia

  Journal of Arrhythmia 28 (1), 4-18, 2012

  日本不整脈学会

キーワード

• Heart failure
• Sensors
• Monitoring

詳細情報

• CRID: 1390001205245002752
• NII論文ID: 130002129813
• DOI: 10.1016/j.joa.2012.02.003
• ISSN: 18832148
• ISSN: 18804276
• Web Site: http://api.elsevier.com/content/article/PII:S188042761200004X?httpAccept=text/xml
• Web Site: http://api.elsevier.com/content/article/PII:S188042761200004X?httpAccept=text/plain
• Web Site: https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.joa.2012.02.003
• Web Site: https://search.jamas.or.jp/link/ui/2015032136
• 本文言語コード: en
• データソース種別:
  • JaLC
  • Crossref
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可